Anita Driessen-Mol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anita Driessen-Mol has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Carlijn V. C. Bouten
Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
9 shared publications - Frank P. T. Baaijens
Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
5 shared publications - Anthal I. P. M. Smits
Department of Biomedical Engineering, Eindhoven University of Technology
3 shared publications A.W. Bosman
SupraPolix BV, Horsten 1, 5612 AX Eindhoven, The Netherlands
2 shared publicationsDaphne van Geemen
Department of Biomedical Engineering, Eindhoven University of Technology , Eindhoven, The Netherlands
2 shared publicationsFrank P.T. Baaijens
Department of Biomedical Engineering, Eindhoven University of Technology , Eindhoven, The Netherlands
2 shared publications
Latest Publications
- 1 April 2018
- Published by Elsevier in Acta Biomaterialia
- Vol. 71, 247-260
Modulation of macrophage phenotype and protein secretion via heparin-IL-4 functionalized supramolecular elastomers
- 1 April 2018
- Published by Elsevier in Acta Biomaterialia
- Vol. 71, 247-260
Modulation of macrophage phenotype and protein secretion via heparin-IL-4 functionalized supramolecular elastomers
- 1 January 2016
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 22 (1-2) , 123-132
Superior Tissue Evolution in Slow-Degrading Scaffolds for Valvular Tissue Engineering
Synthetic polymers are widely used to fabricate porous scaffolds for the regeneration of cardiovascular tissues. To ensure mechanical integrity, a balance between the rate of scaffold absorption and tissue formation is of high importance. A higher rate of tissue formation is expected in fast-degrading materials than in slow-degrading materials. This could be a result of synthetic cells, which aim to compensate for the fast loss of mechanical integrity of the scaffold by deposition of collagen fibers. Here, we studied the effect of fast-degrading polyglycolic acid scaffolds coated with poly-4-hydroxybutyrate (PGA-P4HB) and slow-degrading poly-ɛ-caprolactone (PCL) scaffolds on amount of tissue, composition, and mechanical characteristics in time, and compared these engineered values with values for native human heart valves. Electrospun PGA-P4HB and PCL scaffolds were either kept unseeded in culture or were seeded with human vascular-derived cells. Tissue formation, extracellular matrix (ECM) composition, remaining scaffold weight, tissue-to-scaffold weight ratio, and mechanical properties were analyzed every week up to 6 weeks. Mass of unseeded PCL scaffolds remained stable during culture, whereas PGA-P4HB scaffolds degraded rapidly. When seeded with cells, both scaffold types demonstrated increasing amounts of tissue with time, which was more pronounced for PGA-P4HB-based tissues during the first 2 weeks; however, PCL-based tissues resulted in the highest amount of tissue after 6 weeks. This study is the first to provide insight into the tissue-to-scaffold weight ratio, therewith allowing for a fair comparison between engineered tissues cultured on scaffolds as well as between native heart valve tissues. Although the absolute amount of ECM components differed between the engineered tissues, the ratio between ECM components was similar after 6 weeks. PCL-based tissues maintained their shape, whereas the PGA-P4HB-based tissues deformed during culture. After 6 weeks, PCL-based engineered tissues showed amounts of cells and ECM that were comparable to the number of human native heart valve leaflets, whereas values were lower in the PGA-P4HB-based tissues. Although increasing in time, the number of collagen crosslinks were below native values in all engineered tissues. In conclusion, this study indicates that slow-degrading scaffold materials are favored over fast-degrading materials to create organized ECM-rich tissues in vitro, which keep their three-dimensional structure before implantation.
- 1 January 2016
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 22 (1-2) , 123-132
Superior Tissue Evolution in Slow-Degrading Scaffolds for Valvular Tissue Engineering
Synthetic polymers are widely used to fabricate porous scaffolds for the regeneration of cardiovascular tissues. To ensure mechanical integrity, a balance between the rate of scaffold absorption and tissue formation is of high importance. A higher rate of tissue formation is expected in fast-degrading materials than in slow-degrading materials. This could be a result of synthetic cells, which aim to compensate for the fast loss of mechanical integrity of the scaffold by deposition of collagen fibers. Here, we studied the effect of fast-degrading polyglycolic acid scaffolds coated with poly-4-hydroxybutyrate (PGA-P4HB) and slow-degrading poly-ɛ-caprolactone (PCL) scaffolds on amount of tissue, composition, and mechanical characteristics in time, and compared these engineered values with values for native human heart valves. Electrospun PGA-P4HB and PCL scaffolds were either kept unseeded in culture or were seeded with human vascular-derived cells. Tissue formation, extracellular matrix (ECM) composition, remaining scaffold weight, tissue-to-scaffold weight ratio, and mechanical properties were analyzed every week up to 6 weeks. Mass of unseeded PCL scaffolds remained stable during culture, whereas PGA-P4HB scaffolds degraded rapidly. When seeded with cells, both scaffold types demonstrated increasing amounts of tissue with time, which was more pronounced for PGA-P4HB-based tissues during the first 2 weeks; however, PCL-based tissues resulted in the highest amount of tissue after 6 weeks. This study is the first to provide insight into the tissue-to-scaffold weight ratio, therewith allowing for a fair comparison between engineered tissues cultured on scaffolds as well as between native heart valve tissues. Although the absolute amount of ECM components differed between the engineered tissues, the ratio between ECM components was similar after 6 weeks. PCL-based tissues maintained their shape, whereas the PGA-P4HB-based tissues deformed during culture. After 6 weeks, PCL-based engineered tissues showed amounts of cells and ECM that were comparable to the number of human native heart valve leaflets, whereas values were lower in the PGA-P4HB-based tissues. Although increasing in time, the number of collagen crosslinks were below native values in all engineered tissues. In conclusion, this study indicates that slow-degrading scaffold materials are favored over fast-degrading materials to create organized ECM-rich tissues in vitro, which keep their three-dimensional structure before implantation.
- 1 November 2015
- Published by Elsevier in Acta Biomaterialia
- Vol. 27, 21-31
Hydrolytic and oxidative degradation of electrospun supramolecular biomaterials: In vitro degradation pathways
- 1 November 2015
- Published by Elsevier in Acta Biomaterialia
- Vol. 27, 21-31
Hydrolytic and oxidative degradation of electrospun supramolecular biomaterials: In vitro degradation pathways
- 1 October 2015
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 21 (19-20) , 2583-2594
In Situ Tissue Engineering of Functional Small-Diameter Blood Vessels by Host Circulating Cells Only
Inflammation is a natural phase of the wound healing response, which can be harnessed for the in situ tissue engineering of small-diameter blood vessels using instructive, bioresorbable synthetic grafts. This process is dependent on colonization of the graft by host circulating cells and subsequent matrix formation. Typically, vascular regeneration in small animals is governed by transanastomotic cell ingrowth. However, this process is very rare in humans and, hence, less relevant for clinical translation. Therefore, a novel rat model was developed, in which cell ingrowth from the adjacent tissue is inhibited using Gore-Tex sheathing. Using this model, our aim here was to prove that functional blood vessels can be formed in situ via the host inflammatory response, specifically by blood-borne cells. The model was validated by implanting sex-mismatched aortic segments on either anastomoses of an electrospun polycaprolactone (PCL) graft, filled with fibrin gel, into the rat abdominal aorta. Fluorescent in situ hybridization analysis revealed that after 1 and 3 months in vivo, over 90% of infiltrating cells originated from the bloodstream, confirming the effective shielding of transanastomotic cell ingrowth. Using the validated model, PCL/fibrin grafts were implanted, either or not loaded with Monocyte Chemotactic Protein-1 (MCP-1), and cell infiltration and tissue development was investigated at various key time points in the healing cascade. A phased healing response was observed, initiated by a rapid influx of inflammatory cells, mediated by the local release of MCP-1. After three months in vivo, the grafts consisted of a medial layer with smooth muscle cells in an oriented collagen matrix, an intimal layer with elastin fibers, and confluent endothelium. This study proves the regenerative potential of cells in the circulatory system in the setting of in situ vascular tissue engineering.
- 1 October 2015
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 21 (19-20) , 2583-2594
In Situ Tissue Engineering of Functional Small-Diameter Blood Vessels by Host Circulating Cells Only
Inflammation is a natural phase of the wound healing response, which can be harnessed for the in situ tissue engineering of small-diameter blood vessels using instructive, bioresorbable synthetic grafts. This process is dependent on colonization of the graft by host circulating cells and subsequent matrix formation. Typically, vascular regeneration in small animals is governed by transanastomotic cell ingrowth. However, this process is very rare in humans and, hence, less relevant for clinical translation. Therefore, a novel rat model was developed, in which cell ingrowth from the adjacent tissue is inhibited using Gore-Tex sheathing. Using this model, our aim here was to prove that functional blood vessels can be formed in situ via the host inflammatory response, specifically by blood-borne cells. The model was validated by implanting sex-mismatched aortic segments on either anastomoses of an electrospun polycaprolactone (PCL) graft, filled with fibrin gel, into the rat abdominal aorta. Fluorescent in situ hybridization analysis revealed that after 1 and 3 months in vivo, over 90% of infiltrating cells originated from the bloodstream, confirming the effective shielding of transanastomotic cell ingrowth. Using the validated model, PCL/fibrin grafts were implanted, either or not loaded with Monocyte Chemotactic Protein-1 (MCP-1), and cell infiltration and tissue development was investigated at various key time points in the healing cascade. A phased healing response was observed, initiated by a rapid influx of inflammatory cells, mediated by the local release of MCP-1. After three months in vivo, the grafts consisted of a medial layer with smooth muscle cells in an oriented collagen matrix, an intimal layer with elastin fibers, and confluent endothelium. This study proves the regenerative potential of cells in the circulatory system in the setting of in situ vascular tissue engineering.
- 1 November 2014
- Published by Elsevier in Biomaterials
- Vol. 35 (33) , 9100-9113
Synergistic protein secretion by mesenchymal stromal cells seeded in 3D scaffolds and circulating leukocytes in physiological flow
- 1 November 2014
- Published by Elsevier in Biomaterials
- Vol. 35 (33) , 9100-9113
Synergistic protein secretion by mesenchymal stromal cells seeded in 3D scaffolds and circulating leukocytes in physiological flow
- 1 June 2014
- Published by Elsevier in Biomaterials
- Vol. 35 (18) , 4919-4928
Strain-dependent modulation of macrophage polarization within scaffolds
- 1 June 2014
- Published by Elsevier in Biomaterials
- Vol. 35 (18) , 4919-4928
Strain-dependent modulation of macrophage polarization within scaffolds
- 14 September 2013
- Published by Walter de Gruyter GmbH in Green Processing and Synthesis
- Vol. 2 (5) , 527
Biomimetics: a molecular perspective
Article Biomimetics: a molecular perspective was published on October 1, 2013 in the journal Green Processing and Synthesis (volume 2, issue 5).
- 14 September 2013
- Published by Walter de Gruyter GmbH in Green Processing and Synthesis
- Vol. 2 (5) , 527
Biomimetics: a molecular perspective
Article Biomimetics: a molecular perspective was published on October 1, 2013 in the journal Green Processing and Synthesis (volume 2, issue 5).
- Open Access
- 12 June 2013
- Published by IntechOpen
The Immune Response in In Situ Tissue Engineering of Aortic Heart Valves
- 12 June 2013
- Published by IntechOpen
Open AccessThe Immune Response in In Situ Tissue Engineering of Aortic Heart Valves
- 1 March 2013
- Published by SAGE Publications in Tissue Engineering Part C: Methods
- Vol. 19 (3) , 205-215
The Potential of Prolonged Tissue Culture to Reduce Stress Generation and Retraction in Engineered Heart Valve Tissues
In tissue-engineered (TE) heart valves, cell-mediated processes cause tissue compaction during culture and leaflet retraction at time of implantation. We have quantified and correlated stress generation, compaction, retraction, and tissue quality during a prolonged culture period of 8 weeks. Polyglycolic acid/poly-4-hydroxybutyrate strips were seeded with vascular-derived cells and cultured for 4–8 weeks. Compaction in width, generated force, and stress was measured during culture. Retraction in length, generated force, and stress was measured after release of constraints at weeks 4, 6, and 8. Further, the amount of DNA, glycosaminoglycans (GAGs), collagen, and collagen cross-links was assessed. During culture, compaction and force generation increased to, respectively, 63.9%±0.8% and 43.7±4.3 mN at week 4, after which they remained stable. Stress generation reached 27.7±3.2 kPa at week 4, after which it decreased to ∼8.5 kPa. At release of constraints, tissue retraction was 44.0%±3.7% at week 4 and decreased to 29.2%±2.8% and 26.1%±2.2% at, respectively, 6 and 8 weeks. Generated force (8–16 mN) was lower at week 6 than at weeks 4 and 8. Generated stress decreased from 11.8±0.9 kPa at week 4 to 1.4±0.3 and 2.4±0.4 kPa at, respectively, weeks 6 and 8. The amount of GAGs increased at weeks 6 and 8 compared to week 4 and correlated to the reduced stress and retraction. In summary, prolonged culture resulted in decreased stress generation and retraction, likely as a result of the increased amount of GAGs. These results demonstrate the potential of prolonged tissue culture in developing functional, nonretracting, TE heart valves.
- 1 March 2013
- Published by SAGE Publications in Tissue Engineering Part C: Methods
- Vol. 19 (3) , 205-215
The Potential of Prolonged Tissue Culture to Reduce Stress Generation and Retraction in Engineered Heart Valve Tissues
In tissue-engineered (TE) heart valves, cell-mediated processes cause tissue compaction during culture and leaflet retraction at time of implantation. We have quantified and correlated stress generation, compaction, retraction, and tissue quality during a prolonged culture period of 8 weeks. Polyglycolic acid/poly-4-hydroxybutyrate strips were seeded with vascular-derived cells and cultured for 4–8 weeks. Compaction in width, generated force, and stress was measured during culture. Retraction in length, generated force, and stress was measured after release of constraints at weeks 4, 6, and 8. Further, the amount of DNA, glycosaminoglycans (GAGs), collagen, and collagen cross-links was assessed. During culture, compaction and force generation increased to, respectively, 63.9%±0.8% and 43.7±4.3 mN at week 4, after which they remained stable. Stress generation reached 27.7±3.2 kPa at week 4, after which it decreased to ∼8.5 kPa. At release of constraints, tissue retraction was 44.0%±3.7% at week 4 and decreased to 29.2%±2.8% and 26.1%±2.2% at, respectively, 6 and 8 weeks. Generated force (8–16 mN) was lower at week 6 than at weeks 4 and 8. Generated stress decreased from 11.8±0.9 kPa at week 4 to 1.4±0.3 and 2.4±0.4 kPa at, respectively, weeks 6 and 8. The amount of GAGs increased at weeks 6 and 8 compared to week 4 and correlated to the reduced stress and retraction. In summary, prolonged culture resulted in decreased stress generation and retraction, likely as a result of the increased amount of GAGs. These results demonstrate the potential of prolonged tissue culture in developing functional, nonretracting, TE heart valves.
- 21 February 2013
- Published by Springer Nature in Cell and tissue research
- Vol. 352 (3) , 727-737
Understanding strain-induced collagen matrix development in engineered cardiovascular tissues from gene expression profiles
- 21 February 2013
- Published by Springer Nature in Cell and tissue research
- Vol. 352 (3) , 727-737
Understanding strain-induced collagen matrix development in engineered cardiovascular tissues from gene expression profiles